UBS Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-55,900
Closed -$593K – 9528
2024
Q1
$593K Buy
55,900
+8,800
+19% +$77K ﹤0.01% 5061
2023
Q4
$378K Buy
+47,100
New +$343K ﹤0.01% 5320
2023
Q3
– Sell
-120,000
Closed -$960K – 9465
2023
Q2
$960K Sell
120,000
-27,200
-18% -$201K ﹤0.01% 4290
2023
Q1
$1.19M Buy
147,200
+58,100
+65% +$467K ﹤0.01% 3960
2022
Q4
$560K Sell
89,100
-60,000
-40% -$419K ﹤0.01% 4612
2022
Q3
$1.03M Hold
149,100
– – ﹤0.01% 3736
2022
Q2
$1.25M Sell
149,100
-796,300
-84% -$11.1M ﹤0.01% 3547
2022
Q1
$21.6M Buy
945,400
+672,900
+247% +$16.4M 0.01% 1358
2021
Q4
$7.52M Buy
+272,500
New +$7.29M ﹤0.01% 2402
2020
Q1
– Sell
-118,630
Closed -$3.55M – 7960
2019
Q4
$3.55M Buy
118,630
+4,730
+4% +$123K ﹤0.01% 2937
2019
Q3
$2.49M Sell
113,900
-3,480
-3% -$79.6K ﹤0.01% 3089
2019
Q2
$2.96M Buy
117,380
+1,250
+1% +$29.7K ﹤0.01% 2796
2019
Q1
$2.87M Sell
116,130
-127,250
-52% -$3.04M ﹤0.01% 2664
2018
Q4
$4.5M Sell
243,380
-160,150
-40% -$3.81M ﹤0.01% 2252
2018
Q3
$10.4M Buy
403,530
+61,011
+18% +$1.4M ﹤0.01% 1752
2018
Q2
$7.96M Sell
342,519
-479,481
-58% -$9.9M ﹤0.01% 1933
2018
Q1
$13.1M Buy
822,000
+13,500
+2% +$251K 0.01% 1471
2017
Q4
$16.8M Buy
808,500
+229,000
+40% +$3.63M 0.01% 1309
2017
Q3
$8.3M Sell
579,500
-314,900
-35% -$4.76M ﹤0.01% 1758
2017
Q2
$15.5M Buy
894,400
+694,400
+347% +$8.32M 0.01% 1205
2017
Q1
$2.21M Sell
200,000
-12,300
-6% -$169K ﹤0.01% 2862
2016
Q4
$3.08M Buy
212,300
+10,471
+5% +$192K ﹤0.01% 2524
2016
Q3
$4.96M Buy
201,829
+63,003
+45% +$1.63M ﹤0.01% 2034
2016
Q2
$2.8M Sell
138,826
-984,485
-88% -$27.9M ﹤0.01% 2489
2016
Q1
$29.5M Sell
1,123,311
-3,713,047
-77% -$275M 0.02% 673
2015
Q4
$492M Buy
4,836,358
+4,716,258
+3,927% +$530M 0.32% 59
2015
Q3
$21.4M Buy
120,100
+119,800
+39,933% +$27.9M 0.02% 862
2015
Q2
$67K Sell
300
-1,800
-86% -$399K ﹤0.01% 5734
2015
Q1
$417K Sell
2,100
-210,600
-99% -$37.4M ﹤0.01% 4285
2014
Q4
$30.4M Sell
212,700
-4,300
-2% -$578K 0.02% 748
2014
Q3
$28.5M Sell
217,000
-29,200
-12% -$3.48M 0.02% 747
2014
Q2
$31.1M Buy
246,200
+170,000
+223% +$21.7M 0.02% 653
2014
Q1
$10M Buy
76,200
+21,500
+39% +$2.94M 0.01% 1256
2013
Q4
$6.42M Buy
54,700
+49,100
+877% +$5.38M 0.01% 1634
2013
Q3
$584K Sell
5,600
-92,300
-94% -$8.99M ﹤0.01% 3964
2013
Q2
$8.43M Hold
97,900
– – 0.01% 1172

Other funds holding BHC

UBS Group's BHC Position: Q3 2026 in Review

UBS Group reduced its Bausch Health (BHC) stake by 34% in Q3 2026, selling an estimated $1.47M and leaving 489,508 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #4689.

UBS Group first reported a position in BHC in Q2 2013 and has held it in 54 quarters since. The position peaked at $132M in Q4 2015. 232 funds tracked by Wall St. Rank hold BHC as of Q3 2026.

  • UBS Group held 489,508 shares of Bausch Health worth $2.85M as of Q3 2026.
  • UBS Group sold 254,699 Bausch Health shares in Q3 2026, an estimated $1.47M.
  • Bausch Health made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4689 holding.
  • UBS Group first reported a position in Bausch Health in Q2 2013 and has held it in 54 quarters since.
  • UBS Group's Bausch Health position peaked at $132M in Q4 2015.
  • 232 funds tracked by Wall St. Rank held Bausch Health as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.